ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Artificial Intelligence in Healthcare Strategic Intelligence Report 2025: Transforming Healthcare Through Automation, Analytics, and Smarter Clinical Tools - ResearchAndMarkets.com

The "Strategic Intelligence: Artificial Intelligence in Healthcare (2025)" report has been added to ResearchAndMarkets.com's offering.

Artificial intelligence (AI) is transforming healthcare through automation, analytics, and smarter clinical tools. Across healthcare providers, pharmaceuticals, and medical devices, the combined AI market was valued at $11.9 billion in 2024 and is expected to reach $57.4 billion by 2029, representing a compound annual growth rate (CAGR) of about 37%.

AI consulting and support services are driving healthcare's administrative automation and clinical decision support. AI hardware, including robotics and imaging systems, underpins advances in the medical device sector, while AI platforms and specialized applications are reshaping pharmaceutical research and development (R&D). Collectively, these technologies are moving AI from pilots to scaled commercial adoption.

Report Scope

  • AI adoption is accelerating across healthcare sectors.
  • AI boosts efficiency in drug discovery and development.
  • Regulatory progress accelerates adoption of AI imaging tools.

Reasons to Buy

  • Understand how AI is being used in the healthcare sector.
  • Learn about the major players in AI in healthcare, and where the future of AI in healthcare is going.
  • Access valuable strategic information to enhance future decision-making and inform new product development.

Key Topics Covered:

  • Executive Summary
  • Players
  • Value Chain
  • The Impact of AI on Healthcare
  • Case Studies
  • Companies
  • Sector Scorecards
  • Glossary
  • Further Reading
  • Thematic Research Methodology

Companies Featured

  • AstraZeneca
  • Bristol Myers Squibb
  • Johnson & Johnson
  • Lilly
  • Novartis
  • Pfizer
  • Roche
  • Sanofi
  • GE Healthcare
  • Illumina
  • Medtronic
  • Phillips
  • Siemens Healthineers

For more information about this report visit https://www.researchandmarkets.com/r/qs86zh

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.28
-1.50 (-0.65%)
AAPL  278.03
-0.75 (-0.27%)
AMD  221.43
+0.01 (0.00%)
BAC  54.56
+0.48 (0.89%)
GOOG  313.70
-7.30 (-2.27%)
META  652.71
+2.58 (0.40%)
MSFT  483.47
+4.91 (1.03%)
NVDA  180.93
-2.85 (-1.55%)
ORCL  198.85
-24.16 (-10.83%)
TSLA  446.89
-4.56 (-1.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.